Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of Repeated Subcutaneous Ketamine Injections for Treatment Resistant Depression - The KADS Study: A Randomised, Double-Blind, Comparator-Controlled Trial

  • Colleen K. Loo
  • , Nicholas Glozier
  • , David Barton
  • , Bernhard T. Baune
  • , Natalie Mills
  • , Paul B. Fitzgerald
  • , Paul Glue
  • , Shanthi Sarma
  • , Veronica Galvez-Ortiz
  • , Dusan Hadzi-Pavlovic
  • , Angelo Alonzo
  • , Vanessa Dong
  • , Donel M. Martin
  • , Stevan Nikolin
  • , Philip Bowden Mitchell
  • , Michael Berk
  • , Gregory Carter
  • , Maree Hackett
  • , John Leyden
  • , Sean Hood
    • Andrew Somogyi, Kyle Lapidus, Elizabeth Stratton, Kirsten Gainsford, Deepak Garg, Nicollette Thornton, Celia Fourrier, Karyn Richardson, Demi Rozakis, Anish Scaria, Cathrine Mihalopoulos, Mary Lou Chatterton, William McDonald, Philip Boyce, Paul Holtzheimer, Frank A. Kozel, Patricio Riva-Posse, Anthony Rodgers

Research output: Contribution to journal › Article › Research › peer-review

63   Link opens in a new tab Citations (Scopus)
385 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Repeated Subcutaneous Ketamine Injections for Treatment Resistant Depression - The KADS Study: A Randomised, Double-Blind, Comparator-Controlled Trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases